# Neurogram

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neurogram

- Industry: Medical Devices & Equipment
- Headquarters: Atlanta, US
- Website: www.neurogram.com
- Total disclosed funding: $3M
- Latest round: Seed (Jul 30, 2025)
- Investors on record: 1

## About

Based in the US, Neurogram provides advanced AI tools for efficient management and analysis of electroencephalogram (EEG) exams, enhancing workflow for healthcare professionals in neurology.Neurogram is an Atlanta-based company focused on developing AI solutions for EEG management. Founded in 2021, it has completed 2 deals and raised a total of USD 1.40 mn in funding through a recent round. The specifics about the founder's background are not provided.Neurogram™ specializes in an advanced platform designed for the management and analysis of electroencephalogram (EEG) exams. The core offering enables healthcare professionals to store, manage, and generate EEG reports efficiently, eliminating manual processes traditionally associated with this workflow. Key features include an automated patient questionnaire, online EEG visualization, certified digital signatures, and streamlined report distribution—all aimed at enhancing the user experience for neurologists and technicians. The platform is particularly valuable for clinics and hospitals engaged in neurology and neurophysiology, providing them with tools to improve diagnostic accuracy and operational efficiency. Their services are available in various markets, with a focus on Brazil and potentially expanding to other regions where there is a demand for enhanced neurological diagnostics.Neurogram™ operates primarily on a subscription-based revenue model, allowing clients to access their suite of EEG management tools and services. The pricing structure is designed to cater to different clinical needs, with options that may include tiered subscription plans based on the volume of EEG exams processed. For instance, clinics may subscribe to various packages that dictate the number of reports they can generate weekly, thereby enhancing their operational workflows. The service not only facilitates individual report generation but also enhances overall clinic productivity by automating and streamlining the EEG analysis process. By addressing the needs of healthcare providers, Neurogram™ fortifies its position as a critical partner in the neurology sector, driving sustained revenue through its technology-centric solutions.Neurogram plans to utilize the recently raised USD 1.45 mn in pre-seed funding to enhance its product offerings and expand its market reach. The company is developing new tools aimed at improving the EEG management process, with anticipated releases scheduled for the upcoming year. Additionally, Neurogram is targeting expansion into new geographic regions, specifically focusing on Brazil and other emerging markets, as it aims to meet the growing demand for advanced neurological diagnostics.

## Funding rounds

- Seed, Jul 30, 2025, $3M — Headline

## Investors

- Headline (https://capitalatlas.ai/funds/headline) — Seed